5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial.
JACC Cardiovasc Interv
; 11(5): 462-469, 2018 03 12.
Article
in En
| MEDLINE
| ID: mdl-29519378
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Coronary Artery Disease
/
Cardiovascular Agents
/
Sirolimus
/
Acute Coronary Syndrome
/
Drug-Eluting Stents
/
Percutaneous Coronary Intervention
/
Everolimus
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
JACC Cardiovasc Interv
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
Year:
2018
Type:
Article
Affiliation country:
Netherlands